Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Bristol-Myers Squibb reported $8.48B in Gross Profit on Sales for its fiscal quarter ending in September of 2023.

Gross Profit On Sales Change Date
AbbVie USD 7.46B 2.2B Sep/2023
Abbott USD 5.54B 43M Sep/2023
ALKERMES USD 319.43M 234.71M Sep/2023
Amgen USD 5.1B 119M Sep/2023
AstraZeneca USD 9.43B 15M Sep/2023
Biogen USD 1.87B 7.4M Sep/2023
Bristol-Myers Squibb USD 8.48B 90M Sep/2023
Catalent USD 181M 54M Sep/2023
Gilead Sciences USD 5.49B 329M Sep/2023
GlaxoSmithKline GBP 5.91B 626M Sep/2023
J&J USD 14.74B 2.57B Sep/2023
Merck USD 12.28B 1.24B Sep/2023
Perrigo USD 411.2M 16.8M Sep/2023
Pfizer USD 3.6B 5.73B Sep/2023
Phibro Animal Health USD 67.73M 8.94M Sep/2023
Prestige Brands USD 160.02M 5.35M Sep/2023
Regeneron Pharmaceuticals USD 2.93B 173.1M Sep/2023
Revance Therapeutics USD 37.36M 536K Sep/2023
Roche Holding CHF 22.16B 123M Jun/2023
United Therapeutics USD 539.3M 6.9M Sep/2023
Zoetis USD 1.51B 60M Sep/2023